Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
Phosphorylation at a tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytesF Hirata, K Matsuda, Y Notsu, et al.
Clinical and Experimental Pharmacology & Physiology|May 4, 1999
Effects of apolipoprotein A gene polymorphisms on lipoprotein (a) concentrations in JapaneseH Y Park, T Nabika, Y Notsu, et al.
Japanese Journal of Pharmacology|December 29, 2000
Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinedionesA Suzuki, T Yasuno, H Kojo, et al.
Life Sciences|January 1, 1993
An endothelin ETA receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogsH Nirei, K Hamada, M Shoubo, et al.
Molecular Pharmacology|September 1, 1995
Novel steroid 5 alpha-reductase inhibitor FK143: its dual inhibition against the two isozymes and its effect on transcription of the isozyme genesH Kojo, O Nakayama, J Hirosumi, et al.
Agents and Actions|January 1, 1986
Isolation and characterization of lipocortin (lipomodulin)F Hirata, Y Notsu, R Yamada, et al.
The Prostate|June 1, 1997
FR146687, a novel steroid 5 alpha-reductase inhibitor: in vitro and in vivo effects on prostatesO Nakayama, J Hirosumi, N Chida, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonistK Sogabe, H Nirei, M Shoubo, et al.
European Journal of Pharmacology|June 13, 1994
Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulationY Yokota, N Inamura, M Asano, et al.
Japanese Journal of Pharmacology|November 1, 1993
The pharmacological characterization of FK 739, a new angiotensin II-receptor antagonistK Hamada, Y Nakajima, H Nirei, et al.
Pageof 4